2012:Tetragenetics Announces Results of G-SOMETM- formulated flu vaccine study [ PDF ]
2011:Tetragenetics Announces New CEO and Expands Board of Directors [ PDF ]
2010:Tetragenetics publishes article in BioPharm International Vaccine Supplement [ PDF ]
2010:Tetragenetics introduces the TetraExpress™ and PRISM™ manufacturing platform at BIO 2010
2010:A Phase I SBIR Small Business Catalyst (SBC) grant is awarded from the NIGMS to develop new methods for production of human mAbs using the TetraExpress™ platform
2010:Tetragenetics executes a license to key technology from the University of Georgia
2010:Tetragenetics is awarded a grant from the Bill and Melinda Gates Foundation to explore malaria vaccine development using its PRISM™ technology
2009:A Phase II SBIR grant from the DOE is awarded to Tetragenetics to manufacture novel cellulolytic enzymes
2009:Tetragenetics successfully meets major milestones on proof-of-principle projects with two leading pharmaceutical and life sciences companies
2008:A Phase II STTR grant from the Army Research Office is awarded to Tetragenetics for development of TetraExpress™ as a platform for production of rapidly deployable vaccines
2008:A research collaboration is established with leading enzyme manufacturer New England Biolabs (NEB)
Tetrahymena News
2010:Tetragenetics, NEB and Berkeley scientists publish a study characterizing the secreted proteome of Tetrahymena thermophila
2009:Nobel Prize awarded to Greider, Blackburn and Szostak for discovery of telomeres and teleomerase
